CUSIP: G9381B108
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
6,302,116
-
Share change
-
+306,247
-
Total reported value
-
$101,649,000
-
Price per share
-
$16.13
-
Number of holders
-
41
-
Value change
-
+$21,533,394
-
Number of buys
-
33
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP G9381B108?
CUSIP G9381B108 identifies UROV - UROVANT SCIENCES LTD - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP G9381B108:
Institutional Holders of UROVANT SCIENCES LTD - SHS (UROV) as of Q4 2020
As of 31 Dec 2020,
UROVANT SCIENCES LTD - SHS (UROV) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,302,116 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Beryl Capital Management LLC, VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, GABELLI FUNDS LLC, Orchard Capital Managment, LLC, Candriam Luxembourg S.C.A., GLAZER CAPITAL, LLC, GABELLI & Co INVESTMENT ADVISERS, INC., and K2 PRINCIPAL FUND, L.P..
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.